NXTC
NextCure, Inc. - Common Stock (NXTC)
$18
About NextCure, Inc. - Common Stock (NXTC)
NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.
Details
Daily high
$2.36
Daily low
$1.70
Price at open
$2.00
52 Week High
$15.74
52 Week Low
$1.55
Market cap
7.1M
Dividend yield
0.00%
Volume
288
Avg. volume
109,979
P/E ratio
-.10
NextCure, Inc. - Common Stock News
Details
Daily high
$2.36
Daily low
$1.70
Price at open
$2.00
52 Week High
$15.74
52 Week Low
$1.55
Market cap
7.1M
Dividend yield
0.00%
Volume
288
Avg. volume
109,979
P/E ratio
-.10